Beating Cancer via Early Detection: ASX Stock Targeting Multiple Billion Dollar Markets

This is a paid advertisement from S3 Consortium Pty Ltd. HotCopper does not endorse, approve or have responsibility for the particular offer or statements made. [The Next Biotech]( [The Next Biotech]( [Beating Cancer via Early Detection: ASX Stock Targeting Multiple Billion Dollar Markets]( It is estimated that by 2030, 21.6 million people will develop some form of cancer. While scientists across the world are trying to find a cure, the best way to combat cancer is through early detection. However, existing blood tests can be unreliable and expensive. One ASX listed company is building a portfolio of cancer diagnostics for the screening, diagnosis and monitoring of cancer, based on identifying protein biomarkers in the blood. This company is looking to create a paradigm shift in the early detection market by delivering cheap, less invasive diagnostic tests that could be responsible for saving thousands, if not millions of lives in what amounts to multiple, multi-billion markets. [WOULD YOU LIKE TO KNOW MORE?]( This ASX Life Sciences company has three main areas of focus with a combined market size of over $30 billion. The company’s lead product is a lung cancer test, but it is also developing a test for ovarian cancer. These markets alone are worth $33 billion. Add to that a research stage cancer vaccine project in a $7 billion market and there is a lot of upside to this $28.4 million capped company. The information in this email should not be the only trigger for your investment decision. Click on the link below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions. The company is seeking out major diagnostics, government and Big Pharma partners as it looks to bring its products to commercialisation stage in diagnostic markets across the USA, Europe and Australia. If it can commercialise in these regions, then the company could have a major impact on the lives of cancer sufferers everywhere. [READ OUR FULL ARTICLE]( Regular readers of The Next Oil Rush, The Next Mining Boom, The Next Small Cap and The Next Tech Stock will know that we have a stellar track record of identifying high potential companies. PSC as high as 1,360%, VRC has been up as high as 1,150%, 88E has been up over 680%, EMH as high as 800%, and ICG as high as 525% since we first published articles on these stocks. SAS has been up as high as 870%, BLK has been as high as 600%, FBR has been as high as 530%, ADV as high as 410%, and NOX as high as 390%, since we published articles on these stocks. The past performance of The Next Oil Rush, The Next Mining Boom, The Next Small Cap, The Next Tech Stock, and The Next Biotech, is not and should not be taken as an indication of future performance. Caution should be exercised in assessing past performance. These products, like all other financial products, are subject to market forces and unpredictable events that may adversely affect future performance. S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of Longhou Capital Markets Pty Ltd (AFSL No. 292464). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice. Conflict of Interest Notice S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article. [CUSTOMER NOTICE]( | [PRIVACY POLICY]( | [FINANCIAL SERVICES GUIDE]( | [DISCLOSURE POLICY]( Lvl 1, 530 Little Collins St, Melbourne, Victoria, 3000, AUSTRALIA [HotCopper]( [View this email online]( · [Unsubscribe]( · [Contact Us](mailto:info@hotcopper.com.au) You are receiving this email because you are a member of [HotCopper]( which is owned and operated by Report Card Pty Ltd. ABN: 39 092 598 859 ACN: 092 598 859. This is a paid advertisement. [Advertise on HotCopper](